Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations
- PMID: 17183700
- PMCID: PMC1762338
- DOI: 10.1371/journal.pone.0000069
Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations
Abstract
Background: Vaccine-derived polioviruses (VDPVs) have caused poliomyelitis outbreaks in communities with sub-optimal vaccination. Israeli environmental surveillance of sewage from populations with high (>95%) documented vaccine coverage of confirmed efficacy identified two separate evolutionary clusters of VDPVs: Group 1 (1998-2005, one system, population 1.6x10(6)) and Group 2 (2006, 2 systems, populations 0.7x10(6) and 5x10(4)).
Principal findings: Molecular analyses support evolution of nine Group 1 VDPVs along five different lineages, starting from a common ancestral type 2 vaccine-derived Sabin-2/Sabin-1 recombinant strain, and independent evolution of three Group 2 VDPVs along one lineage starting from a different recombinant strain. The primary evidence for two independent origins was based on comparison of unique recombination fingerprints, the number and distribution of identical substitutions, and evolutionary rates. Geometric mean titers of neutralizing antibodies against Group 1 VDPVs were significantly lower than against vaccine strains in all age-group cohorts tested. All individuals had neutralizing titers >1:8 against these VDPVs except 7% of the 20-50 year cohort. Group 1 VDPVs were highly neurovirulent in a transgenic mouse model. Intermediate levels of protective immunity against Group 2 VDPVs correlated with fewer (5.0+1.0) amino acid substitutions in neutralizing antigenic sites than in Group 1 VDPV's (12.1+/-1.5).
Significance: VDPVs that revert from live oral attenuated vaccines and reacquire characteristics of wild-type polioviruses not only threaten populations with poor immune coverage, but are also a potential source for re-introduction of poliomyelitis into highly immune populations through older individuals with waning immunity. The presence of two independently evolved groups of VDPVs in Israel and the growing number of reports of environmental VDPV elsewhere make it imperative to determine the global frequency of environmental VDPV. Our study underscores the importance of the environmental surveillance and the need to reconsider the global strategies for polio eradication and the proposed cessation of vaccination.
Conflict of interest statement
Figures






Similar articles
-
Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.MMWR Morb Mortal Wkly Rep. 2011 Jul 1;60(25):846-50. MMWR Morb Mortal Wkly Rep. 2011. PMID: 21716199
-
A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.J Virol. 2016 Jun 10;90(13):5978-88. doi: 10.1128/JVI.00277-16. Print 2016 Jul 1. J Virol. 2016. PMID: 27099315 Free PMC article.
-
Oral poliovaccine: will it help eradicate polio or cause the next epidemic?Isr Med Assoc J. 2006 May;8(5):312-5. Isr Med Assoc J. 2006. PMID: 16805227
-
Circulating vaccine-derived polioviruses: current state of knowledge.Bull World Health Organ. 2004 Jan;82(1):16-23. Epub 2004 Feb 26. Bull World Health Organ. 2004. PMID: 15106296 Free PMC article. Review.
-
Vaccine-derived polioviruses and the endgame strategy for global polio eradication.Annu Rev Microbiol. 2005;59:587-635. doi: 10.1146/annurev.micro.58.030603.123625. Annu Rev Microbiol. 2005. PMID: 16153180 Review.
Cited by
-
Advanced environmental surveillance and molecular analyses indicate separate importations rather than endemic circulation of wild type 1 poliovirus in Gaza district in 2002.Appl Environ Microbiol. 2007 Sep;73(18):5954-8. doi: 10.1128/AEM.02537-06. Epub 2007 Jul 27. Appl Environ Microbiol. 2007. PMID: 17660306 Free PMC article.
-
Models and analyses to understand threats to polio eradication.BMC Med. 2017 Dec 22;15(1):221. doi: 10.1186/s12916-017-0991-5. BMC Med. 2017. PMID: 29268738 Free PMC article.
-
The final stages of the global eradication of poliomyelitis.Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120140. doi: 10.1098/rstb.2012.0140. Print 2013 Aug 5. Philos Trans R Soc Lond B Biol Sci. 2013. PMID: 23798688 Free PMC article. Review.
-
Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine.Expert Rev Vaccines. 2018 Aug;17(8):739-751. doi: 10.1080/14760584.2018.1506333. Epub 2018 Aug 9. Expert Rev Vaccines. 2018. PMID: 30056767 Free PMC article. Review.
-
Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina.Appl Environ Microbiol. 2009 Mar;75(5):1395-401. doi: 10.1128/AEM.02201-08. Epub 2009 Jan 5. Appl Environ Microbiol. 2009. PMID: 19124585 Free PMC article.
References
-
- Vidor E, Meschievitz C, Plotkin S. Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine. Pediatr Infect Dis J. 1997;16:312–322. - PubMed
-
- Swartz TA, Handsher R, Manor Y, Stoeckel P, Barkay A, et al. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis. Vaccine. 1998;16:2090–2095. - PubMed
-
- Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, et al. The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance–a review. Gene. 1985;40:1–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources